Brexpiprazole S-oxide-d8

• CAT Number: S000083
• CAS Number: 2748605-29-8
• Molecular Formula: C25H19D8N3O3S
• Molecular Weight: 457.61
• Purity: ≥95%
• IUPAC Name: 7-[4-[2,2,3,3,5,5,6,6-octadeuterio-4-(1-oxo-1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one
• InChI: InChI=1S/C25H27N3O3S/c29-25-9-7-19-6-8-20(18-22(19)26-25)31-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-32(24)30/h3-10,17-18H,1-2,11-16H2,(H,26,29)/i12D2,13D2,14D2,15D2
• InChIKey: VJYXYAVCCLPIPM-DHNBGMNGSA-N
• SMILES: [2H]C1(C(N(C(C(N1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)([2H])[2H])([2H])[2H])C4=C5C=CS(=O)C5=CC=C4)([2H])[2H])[2H]

Brexpiprazole S-oxide-d8 (CAS 2748605-29-8) is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Brexpiprazole S-oxide is essential for studies involving antipsychotic drugs, pharmacokinetics, and metabolic pathways. Featuring eight deuterium atoms, it ensures precise and reliable analytical results. Its advanced formulation provides enhanced stability and consistency, making it suitable for various experimental setups. Ideal for neuropharmacology research and drug development, Brexpiprazole S-oxide-d8 integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.